🇺🇸 routine dose tacrolimus and less myfortic in United States

routine dose tacrolimus and less myfortic (routine dose tacrolimus and less myfortic) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

routine dose tacrolimus and less myfortic in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is routine dose tacrolimus and less myfortic approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for routine dose tacrolimus and less myfortic in United States?

Asan Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.